Genetic Framework Flags Safety Risks for Inflammatory Bowel Disease Drug Targets
A new genetics-based framework systematically flags potential safety risks for inflammatory bowel disease drug targets before broad clinical exposure.
A new genetics-based framework systematically flags potential safety risks for inflammatory bowel disease drug targets before broad clinical exposure.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine